Table 2.
Site | ϕmabs | ϕm | ERR1 | ERR0.025 | |||||
---|---|---|---|---|---|---|---|---|---|
Stom | 11.89 | 11.89 | 21.19 | 19.64 | 0.46 | 120.01 | 82.67 | 0.46 (0.21, 0.80)bca (0.19, 0.79)per |
0.39 (0.15, 0.70)bca (0.15, 0.71)per |
Liver | 36.90 | 36.90 | 34.87 | 27.64 | 1.43 | 291.22 | 76.76 | 1.43 (0.70, 2.41)bca (0.72, 2.39)per |
1.10 (0.49, 1.90)bca (0.40, 1.88)per |
Lung | 36.99 | 13.60 | 16.04 | 14.74 | 0.44 | 37.90 | 4.46 | 0.88 (0.34, 1.50)bca (0.27, 2.07)per |
0.86 (0.40, 1.49)bca (0.32, 2.02)per |
Panc | 11.86 | 11.86 | 16.22 | 14.80 | 9.77 | 1060.94 | 43.77 | 9.77 (3.50a, 14.27)bca (1.72, 55.11)per |
9.12 (3.25b, 13.46)bca (1.49, 48.25)per |
Leuk | 23.66 | 23.66 | 25.40 | 25.29 | 1.69 | 3353.15 | 172.25 | 1.69 (0.20, 4.81)bca (0.19, 4.77)per |
1.17 (0.18, 3.58)bca (0.24, 3.79)per |
ϕmabs: latency (years) which maximises LRT2p-con
ϕm: optimal latency, which maximises LRT2p-con with the constraint ERR1 ≥ 0
: Likelihood Ratio Test for the two-phase model against the control model at ϕm
: Likelihood Ratio Test for the two-phase model against the linear model at ϕm
: fitted parameters for the two-phase model at ϕm
ERR1 : Excess Relative Risk at 10 mSv (lagged by ϕm), as estimated from the fitted two-phase model
ERR0.025 : Excess Relative Risk at 0.25 mSv (lagged by ϕm), as estimated from the fitted two-phase model
bca Bootstrap BCa 95%CI (5000 bootstrap replications)
per Bootstrap percentile 95%CI (1000 bootstrap replications)
a : minimum bootstrap value, lower tail probability = 0.034
b : minimum bootstrap value, lower tail probability = 0.024